%D9%BE%DB%8C%D9%85%DA%A9%D8%B1%D9%88%D9%84%DB%8C%D9%85%D9%88%D8%B3PimecrolimwsPimecrolimusPimecrolimusPimecrolimus%D9%BE%DB%8C%D9%85%DA%A9%D8%B1%D9%88%D9%84%DB%8C%D9%85%D9%88%D8%B3PimecrolimusPimekrolimusPimecrolimus%D0%9F%D0%B8%D0%BC%D0%B5%D0%BA%D1%80%D0%BE%D0%BB%D0%B8%D0%BC%D1%83%D1%81PimekrolimusPimekrolimusPimecrolimusQ417489
about
P2176
P3781
Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo VulgarisReconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic DermatitisAssessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-oldOpen Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical SettingEvaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic DiseaseA Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate ADA Randomized Clinical Trial of the Effect of Pimecrolimus Cream 1% Compared With Topical Corticosteroid in Treatment of Erosive Oral Lichen Planus
P4844
Pimecrolimus and Epidermal Barrier Function1% Topical Pimecrolimus Cream for the Treatment of the Rash Associated With ERBITUXBilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic DermatitisEffect of Pimecrolimus Cream on Cathelicidin Levels in Subjects With EczemaOpen-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under OcclusionComparison of Skin Thickness Under Treatment With Pimecrolimus 1% Cream, Hydrocortisonacetat 1% Cream, Betamethasonvalerat 0,1% Cream and Clobetasol-17-propionat 0,05% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHZ UltrasoundComparison of Atrophogenic Effect of Hydrocortison 1% Cream and Pimecrolimus 1% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHz Ultrasound of Uninvolved Skin in Patients With Atopic DermatitisA Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic DermatitisCutaneous Lupus Erythematosus and ElidelEfficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic DermatitisPimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic DermatitisSafety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) PatientsSafety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca
P921
Q61933009-524BB86A-7D09-4DA9-A896-1EBC342AB2B1Q61933902-2AE291AE-5A36-4E7B-BF18-77606A0AA0DFQ61979309-860BB8E4-BEAF-4AF7-AC7C-8DD798651131Q61979311-943495E2-D147-4036-B8F7-7997D9082669Q61979729-45F33C4F-0C5F-479D-8D09-DB438E698275Q62812589-F371A2AB-EC07-4D75-AEF4-4B2955E8942BQ63319157-8AFBB39B-DD75-465B-B2F4-A106C45FD304
P4844
Q63835278-A22B759F-99AC-483F-BC79-BF5F1FF7C59FQ64640796-7540B13F-BC06-405F-9980-37FC81B6CE40Q64653082-C5143CF0-8EB7-44A6-9D76-0BBCF0BEACC2Q64665349-4A39785C-4683-4E68-9F08-2B438CA4FA2CQ64674124-497DDE19-F685-42D1-8FEE-A11D60734410Q64719826-AE55DAEE-9610-4D04-80E1-B85F1D9ADD5CQ64724431-614FE8FD-E336-4C64-8C00-0099319ECF71Q65381516-5C21C6A7-AE75-4777-BDF1-E0DC385EE31EQ65543824-78311457-A7CB-4736-AF24-59536EA98839Q66030584-AAC48717-FDEB-4A8F-BE88-5B875EAC2C7FQ66032343-F3B38E14-1A04-4309-B25E-00F39662F158Q66032356-F593568C-D3AF-4C94-88AD-52E2A73E69B3Q66059008-EB83B233-1534-4EC7-9EA9-B621CB285CDD
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
component quimic
@oc
name
Pimecrolimus
@de
Pimecrolimus
@es
Pimecrolimus
@nl
Pimecrolimus
@vi
Pimekrolimus
@sh
Pimekrolimus
@sr
pimecrolimus
@en
pimecrolimus
@fr
pimecrolimus
@pt
pimecrolimws
@cy
type
label
Pimecrolimus
@de
Pimecrolimus
@es
Pimecrolimus
@nl
Pimecrolimus
@vi
Pimekrolimus
@sh
Pimekrolimus
@sr
pimecrolimus
@en
pimecrolimus
@fr
pimecrolimus
@pt
pimecrolimws
@cy
altLabel
33-Epi-chloro-33-desoxyascomycin
@en
ASM981
@en
Elidel
@de
Elidel
@nl
Elidel
@pt
Elidel®
@cy
Elidel®
@en
Pimecrolimus
@en
Pimecrolimusum
@en
SDZ ASM 981
@cy
prefLabel
Pimecrolimus
@de
Pimecrolimus
@es
Pimecrolimus
@nl
Pimecrolimus
@vi
Pimekrolimus
@sh
Pimekrolimus
@sr
pimecrolimus
@en
pimecrolimus
@fr
pimecrolimus
@pt
pimecrolimws
@cy
P2868
P486
P592
P6366
P646
P661
P662
P683
P117
P2017
CC[C@@H]1/C=C(/C[C@@H](C[C@@H] ...... @H](C4)OC)Cl)/C)O)C)OC)OC)C)\C
P2067
P2115
N0000148728